Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-909-5 | CAS number: 128-80-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats for the given test chemical. The LD50 value is >5000 mg/kg bw. The study concluded that the LD50 value is >2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to very low vapour pressure of the test chemical, which is reported to be 9.40E-11 Pa (7.05E-013 mmHg). Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Acute Dermal toxicity:
The acute dermal toxicity dose (LD50) was considered based on different studies conducted on rats and rabbits for the given test chemical. The studies concluded that LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- data is from study report
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Determination of the acute oral toxicity of the test substance in rats over a period of 14 observation days.
- GLP compliance:
- no
- Remarks:
- pre-dates GLP-regulation
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Identity: 1,4-bis(p-tolylamino)anthraquinone(BAG)
OTHER SPECIFICS: Safety precautions: Routine hygienic procedure was sufficient to assure personnel health and safety. - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: KLEINTIERFARM MADOERIN AG.; 4414 FUELLINSDORF/SWITZERLAND
- Age at study initiation: approximately 9 weeks
- Weight at study initiation: Males: 150-212 g; Females: 151-191 g
- Fasting period before study: Overnight
- Housing: The animals were caged in groups of five in Macrolon cages type 3 with wire mesh tops and standardized granulated soft wood bedding.
- Identification: By cage number and individual colour spots.
- Diet (e.g. ad libitum): Pelleted standard Kliba 24/343/1 rat maintenance diet,ad libitum.
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-2 degC
- Humidity (%): 55 +/-10 %
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hours/day - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10-25 %
- Amount of vehicle (if gavage): 10-20 ml
- Justification for choice of vehicle: no data
MAXIMUM DOSE VOLUME APPLIED: 20 ml/kg - Doses:
- Group 1: 1000 mg/kg bw
Group 2: 5000 mg/kg bw - No. of animals per sex per dose:
- 5 males , 5 females per group
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Frequency of weighing: 1/week
- Necropsy of survivors performed: yes
- Other examinations performed:
- Mortality: Five times during the day and daily thereafter.
- Body weight: Body weights were recorded at the day of administration and days 7 and 14 after the administration. - Statistics:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortality was observed
- Mortality:
- Mortality was not observed.
- Clinical signs:
- other: 1000 mg/kg: Dyspnea, curved body position, diarrhoea and ruffeld fur. 5000 mg/kg: Sedation, dyspnea, exophthalmos, curved body position, diarrhoea and ruffeld fur. All animals had recovered within 7 observation days.
- Gross pathology:
- No macroscopical organ changes were observed.
- Other findings:
- none
- Interpretation of results:
- other: Not classified
- Conclusions:
- The acute oral LD50 value was considered to be >5000 mg//kg bw, when male and female Wistar rats were treated with the given test chemical via oral: gavage route.
- Executive summary:
The acute oral toxicity study was conducted by using the given test chemical as per OECD Guideline 401 (Acute Oral Toxicity) in male and female Wistar rats at doses from 1000 and 5000 mg/kg bw.
The given test chemical was dissolved in polyethylene glycol (10-25%) and administered as 20 ml/kg via oral gavage route. Animals were observed for mortality five times during the day and daily thereafter. Body weights were recorded at the day of administration and days 7 and 14 after the administration. Necropsy of survivors was performed.
No mortality was observed at 5000 mg/kg bw in treated animals. Clinical signs were observed such as, Dyspnea, curved body position, diarrhoea and ruffeld fur at 1000 mg/kg and Sedation, dyspnea, exophthalmos, curved body position, diarrhoea and ruffeld fur at 5000 mg/kg. All animals had recovered within 7 observation days. Normal development in body weight was observed. No macroscopical organ changes were observed.
Therefore, the acute oral LD50 value was considered to be >5000 mg//kg bw, when male and female Wistar rats were treated with the given test chemical via oral: gavage route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 1 and from study report.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary source.
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- Acute dermal toxicity study was conducted by using the given test chemical.
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Rabbits were received from Pine Acres Rabbi try, West Brattleboro, Vermont
- Age at study initiation: These animals were 8-15 weeks old when obtained.
- Housing: The rabbits were individually housed in stainless steel cages,
- Diet (e.g. ad libitum): Fed Charles River Rabbit Formula (Agway) ad libitum and
- Water (e.g. ad libitum): provided untreated municipal water via water bottles
- Acclimation period: They were quarantined for two weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Animals were maintained at a temperature range of 67°F to 72°F
- Humidity (%): relative humidity range of 35% to 65%
- Air changes (per hr): Rooms are provided 12-16 air changes per hour
- Photoperiod (hrs dark / hrs light): Fluorescent lighting was controlled to provide a 12-hour
light cycle (1 AM to 7 PM). - Type of coverage:
- occlusive
- Vehicle:
- other: 0.9% sodium chloride
- Details on dermal exposure:
- TEST SITE
- Area of exposure: The hair was carefully removed from the back and sides of each animal prior to testing. Oster animal clippers were used for this procedure.
- % coverage: 6 in. x 6 in
- Type of wrap if used: The trunk of the animal was wrapped in plastic wrap and then stockinette to prevent removal of the patches by the animal.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the wrappings and patches were removed.
- Time after start of exposure:24 hour - Duration of exposure:
- 24 hour
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- five male and five female
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were observed 3 times on the day of dosing and twice daily thereafter for signs of toxicity. Body weights were determined twice weekly.
- Necropsy of survivors performed: yes, necropsies were performed on animals dying intercurrently, as well as those surviving treatment and sacrificed on day 14.
- Other examinations performed: Histopathological examination of treated and untreated skin application sites was performed on animals dying during the test period and on 2 animals per sex necropsied at the end of the test period. - Statistics:
- No data
- Preliminary study:
- No data
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed at 2000 mg/kg bw during the 14 day observation period.
- Clinical signs:
- other: The only overt sign of toxicity observed during the study was mild diarrhea displayed by female rabbit 8850 in the afternoon of day 1. This mild diarrhea subsided completely by the morning of day 2.
- Gross pathology:
- There were no gross visible lesions detected upon necropsy of all 10 rabbits at the termination of the study.
- Other findings:
- No data
- Interpretation of results:
- other: Not classified
- Conclusions:
- The acute dermal LD50 value was considered to be >2000 mg/kg bw, when 10 male and female New Zealand White rabbits were treated with the given test chemical by dermal application.
- Executive summary:
The acute dermal toxicity study was conducted by using the given test chemical in 10 male and female New Zealand White rabbits at the dose concentration of 2000 mg/kg bw. The hair was carefully removed from the back and sides of each animal prior to testing. Oster animal clippers were used for this procedure. The powdered test material for the single dose trials was applied uniformly to a 6 in. x 6 in. pad at a dose of 2000 mg/kg, moistened with 0.9% sodium chloride, and secured with surgical tape to the previously clipped and abraded test site. The trunk of the animal was wrapped in plastic wrap and then stockinette to prevent removal of the patches by the animal. After a 24 hour exposure period, the wrappings and patches were removed. All animals were observed 3 times on the day of dosing and twice daily thereafter for signs of toxicity. Body weights were determined twice weekly, and necropsies were performed on animals dying intercurrently, as well as those surviving treatment and sacrificed on day 14. Histopathological examination of treated and untreated skin application sites was performed on animals dying during the test period and on 2 animals per sex necropsied at the end of the test period. No mortality was observed at 2000 mg/kg bw during the 14 day observation period. The only overt sign of toxicity observed during the study was mild diarrhea displayed by female rabbit 8850 in the afternoon of day 1. This mild diarrhea subsided completely by the morning of day 2. The body weights of 3 male and 4 female rabbits either remained constant or increased during the study. Male rabbit 8828 lost approximately 100 grams between days 0 and 3, but regained weight by day 7. Female rabbit 8861 and male rabbit 8810 decreased in weight by 200 grams between days 10 and 14. There were no gross visible lesions detected upon necropsy of all 10 rabbits at the termination of the study.
Hence, the acute dermal LD50 value was considered to be >2000 mg/kg bw, when 10 male and female New Zealand White rabbits were treated with the given test chemical by dermal application.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Data is from secondary source.
Additional information
Acute oral toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for the given test chemical. The studies are summarized as below –
The reported study was mentioned in experimental study report and conducted to assess the toxicological profile of the given test chemical as per OECD Guideline 401 (Acute Oral Toxicity) in male and female Wistar rats at doses from 1000 and 5000 mg/kg bw. The given test chemical was dissolved in polyethylene glycol (10-25%) and administered as 20 ml/kg via oral gavage route. Animals were observed for mortality five times during the day and daily thereafter. Body weights were recorded at the day of administration and days 7 and 14 after the administration. Necropsy of survivors was performed. No mortality was observed at 5000 mg/kg bw in treated animals. Clinical signs were observed such as, Dyspnea, curved body position, diarrhoea and ruffled fur at 1000 mg/kg and Sedation, dyspnea, exophthalmos, curved body position, diarrhoea and ruffled fur at 5000 mg/kg. All animals had recovered within 7 observation days. Normal development in body weight was observed. No macroscopical organ changes were observed. Therefore, the acute oral LD50 value was considered to be >5000 mg//kg bw, when male and female Wistar rats were treated with the given test chemical via oral: gavage route.
The above study report is supported with another experimental study conducted by using the given test chemical. In an acute oral toxicity study, 10 female, 6 weeks old Wistar strain rats were given an oral dose of the given test chemical by gavage at a dose of 10000 mg/kg bw and 10 female, 6 weeks old Wistar strain rats were given an oral dose of test chemical by gavage at a dose of 15000 mg/kg bw. Both groups were observed for 14 days. During the observation period, no death, no clinical signs were observed in any animal. Thus, the lethal concentration (LD50) value for acute oral toxicity test was considered to be >15000 mg/kg bw, when female wistar W70 (SPF) rats were treated with the given test chemical orally via gavage.
This study is supported with the data available in authoritative database for the given test chemical. The acute oral toxicity study was performed by using the given test chemical in rats. Animals were observed for mortality. 50% mortality was observed at dose 3660 mg/kg bw. Hence, the acute oral LD50 value was considered to be 3660 mg/kg bw, when rats were treated with the given test chemical via oral route.
All these studies are further supported with the data available in secondary report for the given test chemical. The acute oral toxicity study was conducted in 10 male and female Fischer 344 rats at dose concentration of 5000 mg/kg bw. The given test chemical was dissolved in corn oil and administered via oral gavage route. Animals were observed frequently on the day of dosing and twice daily thereafter for 14 days. Body weights were measured twice weekly. Rats dying intercurrently as well as those surviving treatment and sacrificed on day 14 were necropsied. No mortality was observed at a dose of 5000 mg/kg to the rats throughout the 14 day observation period. By day 2 of the observation period, the fur on all 10 rats appeared green in colour. On day 4, the fur and tail of the male rats were green, and the fur and tail of the female rats were pale green. By day 14, the male rats were light green in colour. The females appeared light greenish/yellow by day 5, and yellow by day 9. By day 8, the males were light green in colour. All five male and four of the female rats gained or maintained weight throughout the course of the study. Female rat 11424 lost weight between days 7 and 11 but gained weight by day 14. Upon necropsy at terminus, there were no gross internal visible lesions detected in any of the rats. However, all five females were yellow in colour, and all five male rats were light green in colour. Therefore, the acute oral LD50 value was considered to be >5000 mg/kg bw, when 10 male and female Fischer 344 rats were treated with the given test chemical via oral gavage route.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to very low vapour pressure of the test chemical, which is reported to be 9.40E-11 Pa (7.05E-013 mmHg). Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Acute Dermal Toxicity:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and rabbits for the given test chemical. The studies are summarized as below -
The reported study was mentioned in secondary report to determine the acute dermal toxicity dose by using the given test chemical in 10 male and female New Zealand White rabbits at the dose concentration of 2000 mg/kg bw. The hair was carefully removed from the back and sides of each animal prior to testing. Oster animal clippers were used for this procedure. The powdered test material for the single dose trials was applied uniformly to a 6 in. x 6 in. pad at a dose of 2000 mg/kg, moistened with 0.9% sodium chloride, and secured with surgical tape to the previously clipped and abraded test site. The trunk of the animal was wrapped in plastic wrap and then stockinette to prevent removal of the patches by the animal. After a 24 hour exposure period, the wrappings and patches were removed. All animals were observed 3 times on the day of dosing and twice daily thereafter for signs of toxicity. Body weights were determined twice weekly, and necropsies were performed on animals dying intercurrently, as well as those surviving treatment and sacrificed on day 14. Histopathological examination of treated and untreated skin application sites was performed on animals dying during the test period and on 2 animals per sex necropsied at the end of the test period. No mortality was observed at 2000 mg/kg bw during the 14 day observation period. The only overt sign of toxicity observed during the study was mild diarrhoea displayed by female rabbit 8850 in the afternoon of day 1. This mild diarrhoea subsided completely by the morning of day 2. The body weights of 3 male and 4 female rabbits either remained constant or increased during the study. Male rabbit 8828 lost approximately 100 grams between days 0 and 3, but regained weight by day 7. Female rabbit 8861 and male rabbit 8810 decreased in weight by 200 grams between days 10 and 14. There were no gross visible lesions detected upon necropsy of all 10 rabbits at the termination of the study. Hence, the acute dermal LD50 value was considered to be >2000 mg/kg bw, when 10 male and female New Zealand White rabbits were treated with the given test chemical by dermal application.
Another study mentioned in study report was carried out to determine the acute dermal toxicity dose by using the given test chemical as per OECD Guideline 402 (Acute Dermal Toxicity) in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Animals were observed for clinical signs, mortality, until sacrifice. Onset, duration and severity of any sign were recorded. The clinical signs and mortality observations were conducted at 10, 30, 60 minutes, 2, 4 and 6 hours on the day of dosing and once daily thereafter for 14 day. Daily observation was done as far as possible at the same time. The observations were included general clinical signs, observations of eyes, mucous membranes, respiratory, circulatory system and behaviour pattern. Individual animal body weights were recorded pre-test (prior to administration of the test item), day 7 and at termination on day 14. Necropsy was performed on animals surviving at the end of the study. Macroscopic examination of all the orifices, cavities and tissues were made and the findings were recorded. All animals surviving the study period were sacrificed by the carbon dioxide asphyxiation technique (day 15). Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. Hence, LD50 was considered to be >2000mg/kg bw, when male and female Sprague Dawley rats was treated with test chemical by dermal application.
Both the above studies are further supported with the data mentioned in authoritative database by using the given test chemical in rabbits at the concentration of 2000 mg/kg bw. Animals were observed for mortality. No mortality was observed in treated rabbits at 2000 mg/kg bw. Therefore, LD50 value was considered to be >2000 mg/kg bw, when rabbits were treated with the given test chemical by dermal application to the skin.
Thus, based on the above summarised studies for test chemical, it can be concluded that LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies for the test chemical, it can be concluded that LD50 value is >2000 mg/kg bw, for acute oral toxicity and acute dermal toxicity. Thus, comparing these values with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral and acute dermal toxicity. For acute inhalation toxicity wavier was added so, not possible to classify.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.